Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials
Jay S Pepose,1– 3 Shane Foster,4 Christopher Pearson,5 Mitchell Brigell,3 Konstantinos Charizanis3 1Pepose Vision Institute, St. Louis, MO, USA; 2Department of Ophthalmology, Washington University School of Medicine, St. Louis, MO, USA; 3Opus Genetics, Durham, NC, USA; 4Athens Eye Care, Athens, OH,...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2026-02-01
|
| シリーズ: | Clinical Ophthalmology |
| 主題: | |
| オンライン･アクセス: | https://www.dovepress.com/reversal-of-pharmacologic-mydriasis-in-pediatric-subjects-with-ryzumvi-peer-reviewed-fulltext-article-OPTH |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|